Aptevo Therapeutics APVO reported its Q3 earnings results on Tuesday, November 14, 2023 at 08:00 AM.
Here's what investors need to know about the announcement.
Earnings
Aptevo Therapeutics beat estimated earnings by 33.33%, reporting an EPS of $-0.5 versus an estimate of $-0.75.
Revenue was down $0 from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.11 which was followed by a 3.43% increase in the share price the next day.
** Listen to the earnings announcement yourself by clicking here. **
To track all earnings releases for Aptevo Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.